MECP2 and Rett syndrome: Besides, complicated molecular mechanisms underlie the pathology of RTT, and MeCP2 T158M mutation is the most severe mutation in RTT patients28, it is conceivable that restoration of Wnt6/β-catenin signaling is not sufficient to completely rescue these behavioral deficits.